Paper778261
Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.
Bishop NH and 1 other. J Immunol, 1976. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization. Papers, record 778261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/778261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity | Major topic |
| Immunity, Maternally-Acquired | Major topic |
| Syphilis | Major topic |
| Animals | |
| Antibodies, Bacterial | |
| Immune Tolerance | |
| Male | |
| Rabbits | |
| Treponema Immobilization Test | |
| Treponema pallidum |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42516433 | The Treponema pallidum outer membrane protein repertoire and the quest for a syphilis vaccine. | J Bras Doencas Sex Transm | 2026 | https://conductscience.org/library/papers/42516433 | PubMed |
| 42383911 | Advancements in Syphilis Vaccine Development. | Sex Transm Dis | 2026 | https://conductscience.org/library/papers/42383911 | PubMed |
| 42324733 | An mRNA-LNP vaccine expressing TP0435 provides protective immunity in rabbits against Treponema pallidum challenge. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42324733 | PubMed |
| 42262076 | High-throughput profiling of the IgG and IgA response to the Treponema pallidum subsp. pallidum proteome in syphilis patients. | mBio | 2026 | https://conductscience.org/library/papers/42262076 | PubMed |
| 41550954 | Antibodies directed against extracellular loops of FadL orthologs disrupt outer membrane integrity and neutralize infectivity of Treponema pallidum, the syphilis spirochete. | Front Immunol | 2025 | https://conductscience.org/library/papers/41550954 | PubMed |
| 41362418 | The changing epidemiology of syphilis: new strategies for new challenges in China. | Lancet Reg Health West Pac | 2025 | https://conductscience.org/library/papers/41362418 | PubMed |
| 39715273 | Immunodominant extracellular loops of Treponema pallidum FadL outer membrane proteins elicit antibodies with opsonic and growth-inhibitory activities. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39715273 | PubMed |
| 39262771 | A novel pan-proteome array for high-throughput profiling of the humoral response to Treponema pallidum. | iScience | 2024 | https://conductscience.org/library/papers/39262771 | PubMed |
| 39203989 | Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39203989 | PubMed |
| 37090699 | Syphilis vaccine: challenges, controversies and opportunities. | Front Immunol | 2023 | https://conductscience.org/library/papers/37090699 | PubMed |
| 27721440 | Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen. | Nat Rev Microbiol | 2016 | https://conductscience.org/library/papers/27721440 | PubMed |
| 27328030 | Vaccine development for syphilis. | Expert Rev Vaccines | 2017 | https://conductscience.org/library/papers/27328030 | PubMed |
| 24135571 | Current status of syphilis vaccine development: need, challenges, prospects. | Vaccine | 2014 | https://conductscience.org/library/papers/24135571 | PubMed |
| 22133883 | Syphilis: using modern approaches to understand an old disease. | J Clin Invest | 2011 | https://conductscience.org/library/papers/22133883 | PubMed |
| 16418521 | Biological basis for syphilis. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/16418521 | PubMed |
| 16113312 | Quantitative assessment of protection in experimental syphilis. | Infect Immun | 2005 | https://conductscience.org/library/papers/16113312 | PubMed |
| 15845516 | A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. | Infect Immun | 2005 | https://conductscience.org/library/papers/15845516 | PubMed |
| 14500480 | Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K. | Infect Immun | 2003 | https://conductscience.org/library/papers/14500480 | PubMed |
| 12438357 | Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model. | Infect Immun | 2002 | https://conductscience.org/library/papers/12438357 | PubMed |
| 10456928 | T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection. | Infect Immun | 1999 | https://conductscience.org/library/papers/10456928 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/778261
GET https://conductscience.org/api/papers/v1/778261/cited_by?page=2